Hepcidin Serum Levels and Resistance to Recombinant Human Erythropoietin Therapy in Haemodialysis Patients

被引：39

作者：

Costa, Elisio ^{[1
,2
]}

Swinkels, Dorine W. ^{[9
,10
]}

Laarakkers, Coby M. ^{[10
]}

Rocha-Pereira, Petronila ^{[5
]}

Rocha, Susana ^{[3
]}

Reis, Flavio ^{[6
]}

Teixeira, Frederico ^{[6
]}

Miranda, Vasco ^{[7
]}

Faria, Maria do Sameiro ^{[7
]}

Loureiro, Alfredo ^{[8
]}

Quintanilha, Alexandre ^{[2
,4
]}

Belo, Luis ^{[2
,3
]}

Santos-Silva, Alice ^{[2
,3
]}

机构：

[1] Univ Catolica Portuguesa, Inst Ciencias Saude, PT-4200072 Porto, Portugal

[2] Inst Biol Mol & Celular, Porto, Portugal

[3] Fac Farm, Serv Bioquim, Porto, Portugal

[4] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4100 Porto, Portugal

[5] Univ Beira Interior, Ctr Invest Ciencias Saude, Covilha, Portugal

[6] Univ Coimbra, Fac Med, Inst Farmacol & Terapeut Expt, IBILI, Coimbra, Portugal

[7] Dinefro Dialises & Nefrol SA, FMC, Porto, Portugal

[8] Uninefro Sociedade Prestadora Cuidados Med & Dial, Santo Tirso, Portugal

[9] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med 441, NL-6525 ED Nijmegen, Netherlands

[10] Hepcidinanal Com, Nijmegen, Netherlands

来源：

ACTA HAEMATOLOGICA | 2009年 / 122卷 / 04期

关键词：

PROHEPCIDIN;

D O I：

10.1159/000253590

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：226 / 229

页数：4

共 50 条

[31] RESISTANCE TO RECOMBINANT HUMAN ERYTHROPOIETIN THERAPY - A REAL CLINICAL ENTITY
STIVELMAN, JC
SEMINARS IN NEPHROLOGY, 1989, 9 (01) : 8 - 11
[32] IS SERUM HEPCIDIN LEVEL AN INDICATOR OF ATHEROSCLEROSIS IN HAEMODIALYSIS PATIENTS?
Kali, Alaattin
Yayar, Ozlem
Erdogan, Bulent
Eser, Baris
Ercan, Zafer
Buyukbakkal, Mehmet
Merhametsiz, Ozgur
Haspulat, Ayhan
Yildirim, Tolga
Bozkurt, Birkan
Ayli, Mehmet Deniz
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 243 - 243
[33] Serum ferritin level required for adequate response to recombinant human erythropoietin in haemodialysis patients with hepatitis C virus infection
Hung, KY
Wu, DJ
Wu, KD
Chen, WY
Tsai, TJ
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (10) : 2709 - 2710
[34] THE RELATIONSHIP BETWEEN OBESITY AND HEPCIDIN LEVELS IN HAEMODIALYSIS PATIENTS
Sarafidis, Pantelis
Rumjon, Adam
Ackland, Daniel
Maclaughlin, Helen
Bansal, Sukhvinder S.
Macdougall, Iain C.
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 483 - 484
[35] HEPCIDIN ISOFORMS AND THERAPEUTIC EFFECTS OF RECOMBINANT HUMAN ERYTHROPOIETIN IN PATIENTS UNDERGOING MAINTENANCE HEMODIALYSIS
Yokoyama, Takashi
Shimonaka, Yasushi
Sasaki, Yusuke
Yoshida, Yuichi
Yamazaki, Kenro
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 29 - 29
[36] Recombinant human erythropoietin therapy in critically ill patients
D Georgopoulos
D Matamis
N Xirouchaki
C Routsi
A Michalopoulos
A Maggina
G Dimopoulos
E Zakynthinos
G Nakos
G Thomopoulos
K Mandragos
G Vasiliadou
M Peftoulidou
A Maniati
Critical Care, 9 (Suppl 1):
[37] THERAPY WITH HUMAN RECOMBINANT ERYTHROPOIETIN IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
RAZZANO, M
CASLINI, C
CORTELAZZO, S
BATTISTEL, V
RAMBALDI, A
BARBUI, T
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 81 (04) : 628 - 630
[38] Human recombinant erythropoietin therapy
Donato, H
Ferr, H
MEDICINA-BUENOS AIRES, 2006, 66 (01) : 51 - 69
[39] Acute effects of recombinant human erythropoietin on plasma levels of proendothelin-1 and endothelin-1 in haemodialysis patients
Kang, DH
Yoon, KI
Han, DS
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (11) : 2877 - 2883
[40] Pro-hepcidin and hepcidin as diagnostic markers for monitoring the effect of recombinant human erythropoietin and iron in anemic tumor patients
Roeddiger, R.
Hess, G.
Swinkels, D.
Steinmetz, T.
CLINICAL CHEMISTRY, 2007, 53 (06) : A24 - A24

← 1 2 3 4 5 →